These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7650756)

  • 41. Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma.
    Allen JM; Yeats JC; Causon R; Brown MJ; Bloom SR
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1199-204. PubMed ID: 3571423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neonatal administration of a specific neuropeptide Y antiserum alters the vasopressin response to haemorrhage and the hypothalamic content of noradrenaline in rats.
    Vallejo M; Carter DA; Diez-Guerra FJ; Emson PC; Lightman SL
    Neuroendocrinology; 1987 Jun; 45(6):507-9. PubMed ID: 3614553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High concentrations of neuropeptide Y in pituitary portal blood of rats.
    McDonald JK; Koenig JI; Gibbs DM; Collins P; Noe BD
    Neuroendocrinology; 1987 Dec; 46(6):538-41. PubMed ID: 3696385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increase of plasma neuropeptide Y-like immunoreactivity following chronic hypoxia in the rat.
    Cheng JT; Chen CF; Shum AY; Wang JY; Chen HI
    Neurosci Lett; 1992 Jun; 140(2):211-4. PubMed ID: 1501780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuropeptide Y: regional distribution chromatographic characterization and immunohistochemical demonstration in post-mortem human brain.
    Dawbarn D; Hunt SP; Emson PC
    Brain Res; 1984 Mar; 296(1):168-73. PubMed ID: 6201235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radioimmunoassay of neuropeptide Y.
    Allen JM; Yeats JC; Adrian TE; Bloom SR
    Regul Pept; 1984 Jan; 8(1):61-70. PubMed ID: 6546997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients.
    Nilsson C; Karlsson G; Blennow K; Heilig M; Ekman R
    Peptides; 1996; 17(3):359-62. PubMed ID: 8735959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropeptide Y radio-immunoassay: characterization and application.
    Allen R; Boublik J; Hauger RL; Scott N; Rivier J; Brown MR
    Clin Exp Pharmacol Physiol; 1991 Dec; 18(12):825-33. PubMed ID: 1797447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endogenous neuropeptide Y regulates thyroid blood flow.
    Michalkiewicz M; Huffman LJ; Dey M; Hedge GA
    Am J Physiol; 1993 May; 264(5 Pt 1):E699-705. PubMed ID: 8498492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Splanchnic nerve transection abolishes the age-dependent increase of neuropeptide Y-like immunoreactivity in rat adrenal gland.
    Higuchi H; Yang HY
    J Neurochem; 1986 May; 46(5):1658-60. PubMed ID: 3754274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of neuropeptide Y-like immunoreactivity in vertebrate retina.
    Bruun A; Ehinger B; Ekman R
    Exp Eye Res; 1991 Oct; 53(4):539-43. PubMed ID: 1936189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropeptide Y and neuropeptide Y 3-36: isolation from human pancreatic endocrine tumours.
    Shaw C; Cormican K; Thim L; Maule AG; Sloan JM; Buchanan KD
    Regul Pept; 1993 Jun; 45(3):387-94. PubMed ID: 8351404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An examination of neuropeptide Y postmortem stability in an animal model simulating human autopsy conditions.
    Beal MF; Mazurek MF; Lorenz LJ; Chattha GK; Ellison DW; Martin JB
    Neurosci Lett; 1986 Feb; 64(1):69-74. PubMed ID: 3754317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chromatographic and immunological characterisation of neuropeptide Y-like and pancreatic polypeptide-like peptides from the nematode Ascaris suum.
    Smart D; Shaw C; Johnston CF; Halton DW; Fairweather I; Buchanan KD
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Jul; 102(3):477-81. PubMed ID: 1360356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating neuropeptide Y in dog plasma consists of multiple peptide fragments.
    deS Senanayake P; Warner MR; Brosnihan KB; Levy MN; Ferrario CM
    Peptides; 1992; 13(6):1165-73. PubMed ID: 1283629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The primary structure and tissue distribution of an amphibian neuropeptide Y.
    McKay DM; Shaw C; Halton DW; Thim L; Buchanan KD
    Regul Pept; 1992 Jan; 37(2):143-53. PubMed ID: 1539111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The measurement of neuropeptide Y in discrete hypothalamic and limbic regions of male rhesus macaques with a human NPY-directed antiserum.
    Khorram O; Roselli CE; Ellinwood WE; Spies HG
    Peptides; 1987; 8(1):159-63. PubMed ID: 3575147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of neuropeptide Y.
    Balasubramaniam A; Grupp I; Srivastava L; Tatemoto K; Murphy RF; Joffe SN; Fischer JE
    Int J Pept Protein Res; 1987 Jan; 29(1):78-83. PubMed ID: 3570658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epitopic characterization of neuropeptide Y (NPY) by alanine-scanning mutagenesis.
    Deng YJ; Andrews GC; Karush F
    Hybridoma; 1996 Apr; 15(2):159-62. PubMed ID: 8743297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions.
    Angelucci F; Aloe L; Gruber SH; Fiore M; Mathé AA
    Int J Neuropsychopharmacol; 2000 Mar; 3(1):13-25. PubMed ID: 11343574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.